08/11/2024  11:23:04 Diferencia - Volumen Bid29/10/2024 Ask05/11/2024 Capitalización de mecado Dividendo A. P/E Ratio
11.22EUR - 988
Volumen de negocios: 11,080.42
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 9.6 mil millonesEUR - 124.83

Descripción de negocio

Grifols S.A., headquartered in Barcelona, Spain, is a global healthcare company with a track-record of more than 75 years improving people’s health and well-being through the development of plasma protein therapies, hospital pharmacy products and diagnostic technology for clinical use. They have three primary divisions: Bioscience, Diagnostic and Hospital. The company is present in more than 100 countries worldwide and its headquarters are located in Barcelona, Spain. Grifols is a leader in plasma collection with a network of 160 plasma donation centers in the U.S., and is a leading producer of plasma-derived medicines. As a recognized leader in transfusion medicine, Grifols offers a comprehensive range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks, and transfusion centers.
 

Consejo de gestión & Consejo de supervisión

CEO
Nacho Abia
Consejo de gestión
Raimon Grífols Roura, Víctor Grífols Deu, Thomas Glanzmann
Consejo de supervisión
Belén Villalonga Morenés, Carina Szpilka Lázaro, Enrique Felip Font, Iñigo Sánchez- Asiaín Mardones, James Costos, Marla E.Salmon, Raimon Grífols Roura, Ramon Riera Roca, Steven F. Mayer, Tomás Dagá Gelabert, Víctor Grífols Deu, Víctor Grifols Roura
 

Datos de la empresa

Nombre: Grifols S.A.
Dirección: Avinguda de la Generalitat, 152, Parque empresarial Can Sant Joan,ES-08174 Sant Cugat del Vallès, Barcelona
Teléfono: +34-93-5712200
Fax: +34-93-5710267
E-mail: grifols@grifols.com
Internet: www.grifols.com
Industria: Healthcare
Sector: Medical Products
Subsector: Medical Supplies
Fin del año financiero: 31/12
Acciones de libre circulación: 100.00%
Fecha de OPI: -

Relación con inversores

Nombre: -
IR teléfono: +34-93-5710221
IR-fax: +34-93-5712201
IR e-mail: inversores@grifols.com

Accionistas mayoritarios

FreeFloat
 
100.00%